The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE).
 
Alexios Matikas
Honoraria - Veracyte
Speakers' Bureau - Roche; Seagen (Inst)
Research Funding - AstraZeneca (Inst); MSD (Inst); Novartis (Inst); Veracyte (Inst)
 
Bjorn Naume
No Relationships to Disclose
 
Hans Wildiers
Consulting or Advisory Role - Agendia (Inst); Astrazeneca (Inst); Augustine Therapeutics (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Immutep (Inst); Lilly (Inst); MediMix bv (Inst); Menarini (Inst); Novartis (Inst); NV Hict (Inst); Pfizer (Inst); PSI (Inst); Roche (Inst); Seagen (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst)
 
Maria Vittoria Dieci
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending HER2DX licensed to University of Padova
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Roche
 
Gabe Sonke
Consulting or Advisory Role - Biovica (Inst); Novartis (Inst); Seagen (Inst)
Research Funding - Agendia (Inst); AstraZeneca/Merck (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Andreas Karakatsanis
Honoraria - AstraZeneca (Inst); Elsevier; Endomag (Inst); Pfizer (Inst)
Consulting or Advisory Role - Resitu
 
Aglaia Schiza
(OPTIONAL) Uncompensated Relationships - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst)
 
Kevin Punie
Consulting or Advisory Role - AstraZeneca; Eisai; Exact Sciences; Focus Patient; Gilead Sciences; Lilly; Medscape; Menarini; MSD; Mundipharma; Need; Novartis; Pfizer; Roche; Sanofi; Seagen
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; MSD; Pfizer
 
Christos Sotiriou
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; CEPHEID; Merck; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - EISAI; Foundation Medicine; Genomic Health; Prime Oncology; Teva
Patents, Royalties, Other Intellectual Property - A companion diagnostic for CDK4/CDK6 inhibitory drugs based on CDK4 Phosphorylation. Which patient to be treated and how. PCT/EP2017/061780; Epigenetic portraits of human Breast Cancer, PCT/EP2012/050836, WO2012/098215
Travel, Accommodations, Expenses - Roche; Roche/Genentech; Roche/Genentech
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Claudio Vernieri
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Menarini Group; Novartis; Pfizer
Speakers' Bureau - Accademia Nazionale Di Medicina (ACCMED); AstraZeneca; Istituto Gentili; Lilly; Menarini Group; MSD; Novartis; Pfizer
Research Funding - Roche
 
Guillermo Villacampa
Honoraria - Reveal Genomics
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Speakers' Bureau - MSD Oncology; Pfizer; Pierre Fabre
 
Mats Hellström
No Relationships to Disclose
 
Jonas Bergh
Leadership - Asklepios Medicin HB; Coronis and Asklepios Cancer Research AB
Stock and Other Ownership Interests - Stratipath AB
Honoraria - AstraZeneca; Novartis; Roche
Research Funding - Amgen (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - UpToDate
 
Johan Hartman
Leadership - Stratipath AB
Stock and Other Ownership Interests - Stratipath AB
Honoraria - Lilly; MSD; Pfizer
Speakers' Bureau - Gilead Sciences
Research Funding - Cepheid (Inst); Cepheid (Inst); Novartis (Inst)
 
Theodoros Foukakis
Honoraria - UpToDate
Research Funding - AstraZeneca (Inst); Novartis (Inst); Veracyte (Inst)